CLASS II Drug recall · Reported 24 Oct 2018 · FDA Enforcement Report

Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain recalled

Humco Holding Group is recalling Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active, distributed nationwide in the US. The recall was initiated on 28 Aug 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: A24543 Exp. 02/2019; A25724 Exp. 01/2019; A25529 Exp. 04/2019; A25723 Exp. 04/2019; A27120 Exp. 05/2019; A27811 Exp. 06/2019; A28626 Exp. 06/2019; A29171 Exp. 06/2019; A29221 Exp. 06/2019
Quantity recalledUnknown.

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0023-2019
FDA event ID
81061
Recalling firm
Humco Holding Group, Texarkana, TX
Classification
Class II
Status
Terminated
Recall initiated
28 Aug 2018
FDA classified
12 Oct 2018
Reported
24 Oct 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

28 Aug 2018Recall initiated by company
12 Oct 2018Classified by FDA+45 days
24 Oct 2018Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Product as listed by the FDA

Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 100 grams NDC 0395-8077-62 Packaged by: Humco Texarkana, TX 75501 USA

Where it was distributed

Nationwide.

Nationwide

Questions about this recall

Why was it recalled?

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Which lots are affected?

Lots: A24543 Exp. 02/2019; A25724 Exp. 01/2019; A25529 Exp. 04/2019; A25723 Exp. 04/2019; A27120 Exp. 05/2019; A27811 Exp. 06/2019; A28626 Exp. 06/2019; A29171 Exp. 06/2019; A29221 Exp. 06/2019

Where was it sold?

Nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 81061

More recalls from Humco Holding Group

All 5

Other Thyroid recalls

All 11